Quince Therapeutics, Inc. — DEFA14A Filings
7 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Quince Therapeutics, Inc. (QNCX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Quince Therapeutics, Inc. has filed 7 DEFA14A documents with the SEC since 2016. To view all SEC filings by Quince Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
POS AM
POS EX
POSASR
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001662774-25-000026 | Apr 23, 2025 | — |
| DEFA14A | DEFA14A | 0001193125-24-110058 | Apr 24, 2024 | — |
| DEFA14A | DEFA14A | 0001193125-23-102054 | Apr 14, 2023 | — |
| DEFA14A | DEFA14A | 0001193125-22-159688 | May 25, 2022 | — |
| DEFA14A | DEFA14A | 0001193125-22-123573 | Apr 27, 2022 | — |
| DEFA14A | DEFA14A | 0001193125-21-144941 | Apr 30, 2021 | — |
| DEFA14A | DEFA14A | 0001564590-20-017901 | Apr 22, 2020 | — |